These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


604 related items for PubMed ID: 8468607

  • 21. Low-grade gliomas -- current concepts.
    Schramm J, Blümcke I, Ostertag CB, Schlegel U, Simon M, Lutterbach J.
    Zentralbl Neurochir; 2006 May; 67(2):55-66. PubMed ID: 16673237
    [Abstract] [Full Text] [Related]

  • 22. Histone H1.0--a potential molecular marker with prognostic value for patients with malignant gliomas.
    Gabrovsky N, Georgieva M, Laleva M, Uzunov K, Miloshev G.
    Acta Neurochir (Wien); 2013 Aug; 155(8):1437-42. PubMed ID: 23812966
    [Abstract] [Full Text] [Related]

  • 23. Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas.
    Chaichana KL, McGirt MJ, Laterra J, Olivi A, Quiñones-Hinojosa A.
    J Neurosurg; 2010 Jan; 112(1):10-7. PubMed ID: 19361270
    [Abstract] [Full Text] [Related]

  • 24. Adult low-grade glioma: 19-year experience at a single institution.
    Youland RS, Brown PD, Giannini C, Parney IF, Uhm JH, Laack NN.
    Am J Clin Oncol; 2013 Dec; 36(6):612-9. PubMed ID: 22892428
    [Abstract] [Full Text] [Related]

  • 25. Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature.
    Chaichana KL, McGirt MJ, Niranjan A, Olivi A, Burger PC, Quinones-Hinojosa A.
    Neurol Res; 2009 Nov; 31(9):931-9. PubMed ID: 19215664
    [Abstract] [Full Text] [Related]

  • 26. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas.
    Kowalczuk A, Macdonald RL, Amidei C, Dohrmann G, Erickson RK, Hekmatpanah J, Krauss S, Krishnasamy S, Masters G, Mullan SF, Mundt AJ, Sweeney P, Vokes EE, Weir BK, Wollman RL.
    Neurosurgery; 1997 Nov; 41(5):1028-36; discussion 1036-8. PubMed ID: 9361056
    [Abstract] [Full Text] [Related]

  • 27. Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article.
    Ius T, Isola M, Budai R, Pauletto G, Tomasino B, Fadiga L, Skrap M.
    J Neurosurg; 2012 Dec; 117(6):1039-52. PubMed ID: 23039150
    [Abstract] [Full Text] [Related]

  • 28. Delayed leptomeningeal and subependymal seeding after multiple surgeries for supratentorial diffuse low-grade gliomas in adults.
    Alvarez de Eulate-Beramendi S, Rigau V, Taillandier L, Duffau H.
    J Neurosurg; 2014 Apr; 120(4):833-9. PubMed ID: 24286144
    [Abstract] [Full Text] [Related]

  • 29. Practical surgical indicators to identify candidates for radical resection of insulo-opercular gliomas.
    Kawaguchi T, Kumabe T, Saito R, Kanamori M, Iwasaki M, Yamashita Y, Sonoda Y, Tominaga T.
    J Neurosurg; 2014 Nov; 121(5):1124-32. PubMed ID: 25127416
    [Abstract] [Full Text] [Related]

  • 30. Early prognostic factors related to progression and malignant transformation of low-grade gliomas.
    Jung TY, Jung S, Moon JH, Kim IY, Moon KS, Jang WY.
    Clin Neurol Neurosurg; 2011 Nov; 113(9):752-7. PubMed ID: 21889256
    [Abstract] [Full Text] [Related]

  • 31. The effect of waiting for radiotherapy for grade III/IV gliomas.
    Do V, Gebski V, Barton MB.
    Radiother Oncol; 2000 Nov; 57(2):131-6. PubMed ID: 11054516
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of prognostic factors on survival in patients with low grade glioma.
    Durmaz R, Vural M, Işildi E, Coşan E, Ozkara E, Bal C, Ciftçi E, Arslantaş A, Atasoy MA.
    Turk Neurosurg; 2008 Oct; 18(4):336-44. PubMed ID: 19107679
    [Abstract] [Full Text] [Related]

  • 33. Free survival time of recurrence and malignant transformation and associated factors in patients with supratentorial low-grade gliomas.
    Sakarunchai I, Sangthong R, Phuenpathom N, Phukaoloun M.
    J Med Assoc Thai; 2013 Dec; 96(12):1542-9. PubMed ID: 24511718
    [Abstract] [Full Text] [Related]

  • 34. Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects.
    McLendon RE, Akabani G, Friedman HS, Reardon DA, Cleveland L, Cokgor I, Herndon JE, Wikstrand C, Boulton ST, Friedman AH, Bigner DD, Zalutsky MR.
    Nucl Med Biol; 2007 May; 34(4):405-13. PubMed ID: 17499730
    [Abstract] [Full Text] [Related]

  • 35. Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma.
    Winger MJ, Macdonald DR, Cairncross JG.
    J Neurosurg; 1989 Oct; 71(4):487-93. PubMed ID: 2552044
    [Abstract] [Full Text] [Related]

  • 36. Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome.
    Keles GE, Lamborn KR, Berger MS.
    J Neurosurg; 2001 Nov; 95(5):735-45. PubMed ID: 11702861
    [Abstract] [Full Text] [Related]

  • 37. Radiotherapy of malignant gliomas: results from conventional treatment methods and the prospects of advanced techniques.
    Rubino G, Sacco P, Cerase A, Volterrani L, Sebaste L, Pepi F, Pirtoli L.
    Radiol Med; 2004 Nov; 107(1-2):128-35. PubMed ID: 15031704
    [Abstract] [Full Text] [Related]

  • 38. Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases.
    Pollack IF, Claassen D, al-Shboul Q, Janosky JE, Deutsch M.
    J Neurosurg; 1995 Apr; 82(4):536-47. PubMed ID: 7897512
    [Abstract] [Full Text] [Related]

  • 39. Insular gliomas: the case for surgical management.
    Simon M, Neuloh G, von Lehe M, Meyer B, Schramm J.
    J Neurosurg; 2009 Apr; 110(4):685-95. PubMed ID: 19099379
    [Abstract] [Full Text] [Related]

  • 40. Low-grade gliomas.
    Stieber VW.
    Curr Treat Options Oncol; 2001 Dec; 2(6):495-506. PubMed ID: 12057095
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 31.